Navigation Links
A new kind of rat model
Date:9/13/2007

sorders related to learning and memory. Insights from the research could lead to a wide spectrum of related research, he says.

The impairments that we saw in one consomic strain are similar to some of the symptoms that you see in human children with autism or attention deficit hyperactivity disorder (ADHD), Swain says.

Test results so far have shown that some of the consomic rats exhibited increased depressive-like behavior, increased pain sensitivity, lower expression of anxiety and enhanced learning in spatial navigation tasks.

The researchers say their findings illustrate the role of genetics on behavior.

Since my lab has been studying how angiogenesis (the creation of new blood vessels) contributes to better learning, we were very interested to see how this consomic strain performed on a variety of learning tasks, he says.

PhysioGenix, which opened its lab six years ago, licensed the intellectual property from MCW that allows it to commercialize the consomic rats, and the company is finding new applications for them. Howard Jacob, one of the founders of PhysioGenix, is also director of the Human Molecular Genetics Center at MCW. He was instrumental in creating the consomic rats, and was a leader in the rat genome sequencing project funded through the National Institutes of Health. Richard Roman, director of the Kidney Disease Institute at MCW, also is a co-founder of PhysioGenix.

Together, researchers at PhysioGenix, along with their UWM partners, will be presenting three papers at the annual meeting of the Society for Neuroscience in November.

Ultimately, PhysioGenix plans to distribute the consomic rats to academic researchers for studying human neurological diseases and to pharmaceutical researchers for developing new drug therapies.


'/>"/>

Contact: Steven Nye
snye@PhysioGenix.com
University of Wisconsin - Milwaukee
Source:Eurekalert

Page: 1 2

Related biology news :

1. Study Models Impact Of Anthrax Vaccine
2. Scientists identify new model Of NK cell development
3. Research Using Mouse Models Reveals A Novel Key Player In The Initiation Of Colon Cancer
4. Genrate: a generative model that finds and scores new genes and exons in genomic microarray data
5. Molecular models advance the fight against malaria
6. NYU and MSKCC research provides model for understanding chemically induced cancer initiation
7. Genetic therapy reverses nervous system damage in animal model of inherited human disease
8. Disease progression model of pancreatic cancer developed by Penn researchers
9. A new way to share models of biological systems
10. Understanding biases in epidemic models important when making public health predictions
11. Climate model links higher temperatures to prehistoric extinction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... A new study reports that an expansion of marine ... perform key ecological functions. According to investigators from ... at protecting fish have focused on saving the largest ... species that provide key and difficult-to-replace ecological functions. ... are performed by fish species that also are food ...
(Date:8/28/2014)... Clinic researcher and his collaborators have developed an online ... process of re-engineering cells for biomedical investigation. CellNet is ... to aid stem cell engineering. Details of CellNet and ... two back-to-back papers in the journal Cell . ... uses for all types of cell-based investigations and can ...
(Date:8/28/2014)... on-off switch for Streptomyces , a group of ... world,s naturally derived antibiotic medicines. , Their hope ... to manipulate this switch to make nature,s antibiotic factory ... in Cell , found that a unique interaction ... protein called BldD ultimately controls whether a bacterium spends ...
Breaking Biology News(10 mins):Study finds marine protected areas inadequate for protecting fish and ocean ecology 2New tool aids stem cell engineering for medical research 2Small molecule acts as on-off switch for nature's antibiotic factory 2Small molecule acts as on-off switch for nature's antibiotic factory 3
... in their fight against a dangerous bacterium that sickens ... such as catheters, artificial joints and heart valves. , ... has, for the first time, been shown to protect ... would otherwise kill the bacteria, according to scientists at ...
... access publishing and the NIH new policy from ... of Health (NIH) rule on Enhanced Public Access to ... and a missed opportunity to take advantage of available ... the nation's leading not-for-profit medical and scientific publishers. The ...
... follow up of the NIH public access policy announced ... Central : , BioMed Central welcomes the announcement ... access policy. The NIH calls on all of its grantees ... National Library of Medicine's PubMed Central and make them freely ...
Cached Biology News:Substance protects resilient staph bacteria 2Not-for-profit publishers call NIH public access rule a missed opportunity 2Not-for-profit publishers call NIH public access rule a missed opportunity 3BioMed Central welcomes the new National Institutes of Health public access policy 2
(Date:8/27/2014)... Belmont, Mass. (PRWEB) August 27, 2014 ... of top technology vendors,” said Ven Thangaraj, CEO of ... imaging solutions that are taking the imaging corelab market ... trial sponsors, corelabs and research organizations to efficiently and ... and prepare the data to be analyzed and read ...
(Date:8/27/2014)... , Aug. 27, 2014 Reportbuyer.com ... The Graphene Opportunity - A Rational View ... Graphene The New Nanotech? A similar amount ... of applications ranging from microelectronics to water treatment, ... announced the availability of the Graphene Opportunity Report, ...
(Date:8/27/2014)... 2014 Research and Markets has ... Pulp & Paper Industry Report 2014" report to ... Pulp & Paper Industry Report 2014 is a professional ... global enzyme for pulp & paper industry. ... including definitions, classifications, applications and industry chain structure. The ...
(Date:8/27/2014)... Aug. 27, 2014  ARCH Venture Partners, one ... in the development of seed and early-stage advanced ... fund closed with more than $400 million in ... million subscription target by more than $150 million. ... the strength and potential of our approach to ...
Breaking Biology Technology:Radiant Sage Named to CIOReview List of 100 Most Promising Technology Companies 2The Graphene Opportunity - A Rational View 2The Graphene Opportunity - A Rational View 3The Graphene Opportunity - A Rational View 4Global Enzyme for Pulp & Paper Industry Report 2014 2Latest ARCH Venture Partners Fund Closes Above $400 Million 2Latest ARCH Venture Partners Fund Closes Above $400 Million 3
... to Initiate Phase II Trial for IPLEX(TM) in ... Sweden, Sept. 23 ,Insmed Inc. (Nasdaq CM: INSM), ... Premacure AB, a biopharmaceutical company,dedicated to the development ... to premature birth, today noted the presentation of,clinical ...
... REDWOOD CITY, Calif., Sept. 23 Codexis, Inc., ... Vice President,Intellectual Property. She will be responsible for ... portfolio and will,report to Douglas Sheehy, Vice President, ... Codexis from Danisco A/S, where as Senior,Director, Intellectual ...
... 23 /PRNewswire-FirstCall/ - Spectral Diagnostics Inc.,(TSX: SDI) today ... with Toray,Industries Inc. of Japan to obtain the ... Toraymyxin(TM), a therapeutic for the treatment of,sepsis that ... of the,agreement, the Company will seek FDA approval ...
Cached Biology Technology:Insmed and Premacure Cite Study Results Demonstrating Potential Effectiveness of IPLEX(TM) in Preventing Blindness in Premature Infants 2Insmed and Premacure Cite Study Results Demonstrating Potential Effectiveness of IPLEX(TM) in Preventing Blindness in Premature Infants 3Insmed and Premacure Cite Study Results Demonstrating Potential Effectiveness of IPLEX(TM) in Preventing Blindness in Premature Infants 4Insmed and Premacure Cite Study Results Demonstrating Potential Effectiveness of IPLEX(TM) in Preventing Blindness in Premature Infants 5Codexis Names Vice President, Intellectual Property 2Spectral to bring anti-sepsis therapy to the U.S. market 2Spectral to bring anti-sepsis therapy to the U.S. market 3
... The ScriptCap™ 2'-O-Methyltransferase converts Cap 0 ... mRNA. The Cap 1 structure has been ... by up to 50%. This improvement is ... the ScriptCap™ m7G Capping System as well ...
Form: Concentrated Applications: ELISA...
Form: Ready to use Applications: ELISA...
RABBIT ANTI HALOPERIDOL...
Biology Products: